Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma - Concepedia

Concepedia

Publication | Open Access

Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma

DOI Full Paper Access

206

Citations

19

References

2016

Year

Caroline Happold, Thierry Gorlia, Olivier Chinot, Mark R. Gilbert, Burt Nabors, Wolfgang Wick, Stephanie L. Pugh, Monika E. Hegi, Timothy F. Cloughesy, Patrick Roth,

Journal of Clinical Oncology

Abstract

The results of this analysis do not justify the use of VPA or LEV for reasons other than seizure control in patients with newly diagnosed glioblastoma outside clinical trials.

References

	Year	Citations

Page 1